This inventor holds 4 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Nucorion Pharmaceuticals, Inc.. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: Zucai Suo: Innovator in Pharmaceutical Chemistry
Introduction
Zucai Suo is a prominent inventor based in Dublin, OH (US), known for his significant contributions to pharmaceutical chemistry. He holds a total of 4 patents that focus on innovative treatments for viral infections and cancer. His work has the potential to impact the medical field significantly.
Latest Patents
One of Suo's latest patents is centered around Gemcitabine analogs. These analogs, including monophosphorylated variants, are designed for use in pharmaceutical compositions, kits, and treatment methods. The treatment methods outlined in this patent include addressing viral infections, such as Hepatitis C Virus, and various forms of uncontrolled cellular proliferation, including several types of cancer like non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, liver cancer, esophageal cancer, and lymphoma. Another notable patent involves substituted gemcitabine bicyclic amide analogs. This invention relates to substituted gemcitabine aryl amide analogs, their derivatives, and related compounds. It also covers synthesis methods for these compounds, pharmaceutical compositions that include them, and methods for treating viral disorders and uncontrolled cellular proliferation.
Career Highlights
Zucai Suo is currently associated with Nucorion Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the pharmaceutical sector. His work is characterized by a commitment to innovation and improving treatment options for serious health conditions.
Collaborations
Suo collaborates with notable colleagues, including David J Taggart and Sheng Cao, who contribute to his research endeavors and help drive forward the development of new pharmaceutical solutions.
Conclusion
Zucai Suo's innovative work in pharmaceutical chemistry, particularly in the development of Gemcitabine analogs, showcases his dedication to addressing critical health challenges. His contributions are poised to make a lasting impact in the field of medicine.